CompletedPhase 2NCT02910531
Lipoic Acid Supplement for Cystine Stone
Studying Cystinuria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Thomas Chi, MD
- Principal Investigator
- Thomas Chi, MD, M.DUniversity of California, San Francisco
- Intervention
- Alpha lipoic acid(dietary_supplement)
- Enrollment
- 50 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2017 – 2025
Study locations (1)
- University of California, San Francisco, San Francisco, California, United States
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02910531 on ClinicalTrials.govOther trials for Cystinuria
Additional recruiting or active studies for the same condition.